ScienceDaily (Jan. 27, 2010) — Childhood cancer survivors who had brain or other central nervous system cancers, or leukemia, achieve lower-than-expected educational success compared with the general public, according to an article published online January 27 in the Journal of the National Cancer Institute.
This study was undertaken because previous studies on educational attainment among childhood cancer survivors were small, had contradictory findings, or were not population-based....
ProCure Proton Therapy Center in Oklahoma City Treating Pediatric Patients
OKLAHOMA CITY--(BUSINESS WIRE)--Children with cancer are now being accepted for treatment at the ProCure Proton Therapy Center in Oklahoma, where a wide range of tumors are treated with proton therapy, an alternative to X-ray radiation that spares healthy tissue and results in far fewer short- and long-term treatment side effects.
Survivors of childhood central nervous system malignancies had a higher risk for neurocognitive impairment that was associated with lower socioeconomic achievements in adulthood, according to recently published data.
As part of the Childhood Cancer Survivor Study being conducted at nine major medical centers, researchers assessed neurocognitive functioning in 785 adult survivors of childhood CNS malignancies and compared them...
ScienceDaily (July 15, 2009) — Research from the Masonic Cancer Center, University of Minnesota indicates that a baby born to an older mother may have a slightly increased risk for many of the cancers that occur during childhood.
“Our finding shows that although the absolute risk is low, advancing maternal age may be a factor and explain why, after other factors are adjusted for, some children get cancer,” said Logan Spector, Ph.D., assistant professor of pediatrics and cancer epidemiology...
Retinoblastoma survivors at long-term risk for death from subsequent malignant neoplasms
Posted April 17, 2009
Patients who survive hereditary retinoblastoma may be at increased risk for death from subsequent sarcomas, melanomas and cancers of the brain and nervous system as many as 40 years after their retinoblastoma diagnosis, according to follow-up data from a retrospective cohort study. Additionally, patients treated with radiotherapy were at a greater risk compared...
